|
Indian Pediatr 2016;53: 745 |
|
Ibuprofen-induced DRESS Syndrome in a Child
|
Tugba Koca and *Mustafa
Akcam
Division of Pediatric Gastroenterology, Hepatology and
Nutrition, Department of Pediatrics, Süleyman Demirel University School
of Medicine, Isparta, Turkey.
Email: [email protected]
|
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) is a rare
drug-induced hypersensitivity syndrome with life-threatening
complications. Although there are a few reported cases of
ibuprofen-induced DRESS syndrome in adults [1], It has not been reported
in children. We report here a child with DRESS syndrome triggered by
ibuprofen.
An 11-year-old boy was admitted with complaints of
fever, and rash on the face and body for last five days. He had used
ibuprofen for a few days due to myalgia and fever about a month ago. He
was febrile and had maculopapular rash on face, body and legs.
Laboratory findings were: hemoglobin 13.4 g/dL, white cell count
10400/mm 3, platelet count
360000/mm3, absolute
eosinophil count 1560/mm3,
total bilirubin 3.2 mg/dL, direct bilirubin 1.7 mg/dL. ESR 49 mm/h, CRP
33 mg/dL, ALT 69 IU/L, AST 63 IU/L and GGT 101 IU/L. Blood culture and
throat culture were negative. Serological tests for Epstein-Barr,
cytomegalovirus, HHV-6, hepatitis A, hepatitis B, hepatitis C, HIV, and
parvovirus B19 were negative. Hepatobiliary ultrasonography showed
normal findings. His skin rash and fever regressed, and transaminase
level decreased in 48 hours after starting oral methylprednisolone (2
mg/kg/day). Three weeks later, he had no complaints, and laboratory
findings were all in normal ranges.
DRESS syndrome usually occurs 2-6 weeks after
exposure to the causative drug. The skin, liver, and hematological
system are most commonly involved. Hematological abnormalities are
leukocytosis, eosino-philia and atypical lymphocytes [2].
Other manifestations are lymph node enlargement,
pneumonia, nephritis, myocarditis, encephalitis, and rarely
pancreatitis. The child’s score for defining DRESS syndrome was seven,
and this pointed to ’definite case’ [2].
Rapid response to corticosteroids also supported our
diagnosis.
Differential diagnoses of DRESS syndrome include
Steven-Johnson syndrome, toxic epidermal necrolysis, rheumatological
diseases, and infectious diseases. Pathogenesis of DRESS syndrome is not
well known. Hypersensitivity reaction secondary to circulating
anti-bodies or toxic metabolites is implicated; herpesvirus-6 is also
postulated to play a role in its etiology [3]. The incidence is
approximately 1 in 1,000 to 1 in 10,000 exposures [4].
DRESS syndrome has a mortality rate of 10–20%,
with most fatalities resulting from liver failure.
Drugs mostly related with DRESS are anti-convulsants,
sulfa derivatives, antimicrobials and anti-inflammatory drugs, with only
a few adult cases related to ibuprofen [2,5].
To our knowledge, this is probably the first
report on DRESS syndrome triggered by ibuprofen in the pediatric age
group.
Contributors: TK, MA: management of cases;
TK,:wrote the manuscript; MA: final approval of manuscript.
Funding: None; Competing interest: None
stated.
References
1. Roales-Gómez V, Molero AI, Pérez-Amarilla I,
Casabona-Francés S, Rey-Díaz-Rubio E, Catalán M, et al. DRESS
syndrome secondary to ibuprofen as a cause of hyperacute liver failure.
Rev Esp Enferm Dig. 2014;106:482-6.
2. Kardaun SH, Sidoroff A, Valeyrie-Allanore L,
Halevy S, Davidovici BB, Mockenhaupt M, et al. Variability in the
clinical pattern of cutaneous side-effect of drugs with systematic
symptoms: doers a DRESS syndrome really exist? Br J Dermatol.
2007;156:609-11.
3. Tohyama M, Yahata Y, Yasukawa M, Inagi R, Urano
Y, Yamanishi K, et al. Severe hypersensitivity syndrome due to
sulfasalazine associated with reaction of human herpes virus 6. Arch
Dermatol. 1998;134:1113-7.
4. Walsh SA, Creamer D. Drug reaction with
eosinophilia and systemic symptoms (DRESS): a clinical update and review
of current thinking. Clin Exper Dermatol. 2010;36:6-11.
5. Akcam FZ, Aygun FO, Akkaya VB. DRESS like severe drug rash with
eosinophilia, atypic lymphocytosis and fever secondary to ceftriaxone. J
Infect. 2006;53:51-3.
|
|
|
|